# A Factor IX Gene Therapy Study (FIX-GT)

> **NCT03369444** · PHASE1,PHASE2 · TERMINATED · sponsor: **University College, London** · enrollment: 10 (actual)

## Conditions studied

- Hemophilia B

## Interventions

- **BIOLOGICAL:** FLT180a

## Key facts

- **NCT ID:** NCT03369444
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-05
- **Primary completion:** 2020-10-20
- **Final completion:** 2020-10-20
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Terminated early due to challenges during the COVID-19 pandemic and a change in requirements of data to be submitted for marketing authorisation.
- **Last updated:** 2022-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03369444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03369444, "A Factor IX Gene Therapy Study (FIX-GT)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03369444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*